American Airlines approves Envirotainer pharma containers

American Airlines has approved the Envirotainer Releye RLP and RAP containers for use on its fleet of aircraft to increase shipment options for pharmaceuticals.

The approval is expected to help the airline better meet demand to deliver medicines that need to be temperature-controlled in transit while providing pharma shippers with sustainable cold chain solutions.

Envirotainer’s Releye containers were “created with a focus on control, monitoring, autonomy, and reliability to minimise the likelihood of valuable product loss that could negatively impact patients’ health outcomes”, said Envirotainer.

“We are thrilled to offer our customers another option for moving temperature-sensitive freight with us. The Releye RLP and RAP containers are reliably designed for transporting critical Life Sciences and Pharmaceutical shipments, making it a perfect addition to our current cold-chain network,” said Eric Mathieu, head of customer experience for American Airlines Cargo.

“The addition of American Airlines to the growing family of carriers of our Releye containers is a significant milestone,” said Don Harrison, interim chief sales officer at Envirotainer.

He added: “American Airlines can now provide its customers with the latest fully connected solution to ensure the safety and quality of air freight pharmaceutical products throughout the supply chain.”

Envirotainer pharma shipments up

Envirotainer boosts production to meet high demand for pharma